This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krajewska, M. Articles by Reed, J. C. Search for Related Content PubMed PubMed Citation Articles by Krajewska, M. Articles by Reed, J. C.

American Journal of Pathology, Vol 149, 1449-1457, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach

M Krajewska, CM Fenoglio-Preiser, S Krajewski, K Song, JS Macdonald, G Stemmerman and JC Reed
Burnham Institute, La Jolla, California 92037, USA.

The apoptosis-regulating proteins Bcl-2, Bax, Bcl-X, Bak, and Mcl-1 were examined by immunohistochemical methods in 48 archival specimens of adenocarcinoma of the stomach, and the results were correlated with tumor histology (intestinal versus diffuse pattern) and clinical stage (early- versus late-stage disease, ie, stages I and II versus stage III). Tumor cells containing immunostaining for the anti-apoptotic proteins Bcl-2, Bcl-X, and Mcl-1 were present in 26 (54%), 41 (85%), and 36 (75%) of the 48 cases evaluated, respectively, whereas immunopositivity for the pro-apoptotic proteins Bax and Bak was found in 44 (92%) and 42 (88%) specimens Comparisons of these immunostaining results with tumor histology revealed statistically significant differences for Bax (P = 0.03), Bcl-X (P = 0.003), and Mcl-1 (P = 0.005), which were all more frequently immunopositive for tumors with an intestinal than a diffuse histological pattern (chi 2 analysis). In addition, the percentage of immunopositive tumor cells was significantly higher for Bcl-X (62 +/- 6% versus 45 +/- 6%, mean +/- SE, P = 0.01) and for Mcl-1 (48 +/- 6% versus 30 +/- 6%; P = 0.04) in tumors with intestinal versus diffuse histology (unpaired t-test). In contrast, the percentage of Bcl-2-immunopositive tumor cells was higher in tumors with diffuse histology compared with intestinal (32 +/- 5% versus 12 +/- 5%; P = 0.01), whereas the percentages of Bax- and Bak- immunopositive tumor cells were not significantly different between these two histological types. In 34 specimens, residual normal gastric epithelial cells (foveolar cells) were present for direct comparisons of immunointensity with tumor cells. The immunointensity for the Bcl-2, Bcl-X, and Mcl-1 proteins was stronger in tumor cells compared with normal foveolar cells in 7 (21%), 15 (44%), and 8 (2.1%) of 34 cases, respectively, whereas the immunointensity of the proapoptotic proteins Bax and Bak was reduced compared with normal cells in 8 (24%) and 24 (71%) cases. Immunointensity, however, did not correlate with histology. clinical stage was not significantly associated with the presence or absence of immunopositive tumor cells, the percentage of immunopositive cells, or immunointensity. Taken together, these results establish for the first time that several Bcl-2 family proteins are expressed in gastric adenocarcinomas and suggest that the repertoire of these proteins may differ depending on the histological type. The findings therefore support the notion that the intestinal and diffuse types of gastric cancer arise at least in part through different mechanisms.

This article has been cited by other articles:

				P. Kumar, I. K. Coltas, B. Kumar, D. B. Chepeha, C. R. Bradford, and P. J. Polverini Bcl-2 Protects Endothelial Cells against {gamma}-Radiation via a Raf-MEK-ERK-Survivin Signaling Pathway That Is Independent of Cytochrome c Release Cancer Res., February 1, 2007; 67(3): 1193 - 1202. [Abstract] [Full Text] [PDF]

				T. Grimm, S. Schneider, E. Naschberger, J. Huber, E. Guenzi, A. Kieser, P. Reitmeir, T. F. Schulz, C. A. Morris, and M. Sturzl EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX Blood, April 15, 2005; 105(8): 3263 - 3269. [Abstract] [Full Text] [PDF]

				H. W. Lee, S.-S. Lee, S. J. Lee, and H.-D. Um Bcl-w Is Expressed in a Majority of Infiltrative Gastric Adenocarcinomas and Suppresses the Cancer Cell Death by Blocking Stress-activated Protein Kinase/c-Jun NH2-terminal Kinase Activation Cancer Res., March 1, 2003; 63(5): 1093 - 1100. [Abstract] [Full Text] [PDF]

				Y Suzuki, T Honma, S Hayashi, Y Ajioka, and H Asakura Bcl-2 expression and frequency of apoptosis correlate with morphogenesis of colorectal neoplasia J. Clin. Pathol., March 1, 2002; 55(3): 212 - 216. [Abstract] [Full Text] [PDF]

				S. Kondo, Y. Shinomura, Y. Miyazaki, T. Kiyohara, S. Tsutsui, S. Kitamura, Y. Nagasawa, M. Nakahara, S. Kanayama, and Y. Matsuzawa Mutations of the bak Gene in Human Gastric and Colorectal Cancers Cancer Res., August 1, 2000; 60(16): 4328 - 4330. [Abstract] [Full Text]

				S. Renner, J. Weisz, S. Krajewski, M. Krajewska, J. C. Reed, and A. Lichtenstein Expression of BAX in Plasma Cell Dyscrasias Clin. Cancer Res., June 1, 2000; 6(6): 2371 - 2380. [Abstract] [Full Text]

				Y. Soini, V. Kinnula, R. Kaarteenaho-Wiik, E. Kurttila, K. Linnainmaa, and P. Paakko Apoptosis and Expression of Apoptosis Regulating Proteins bcl-2, mcl-1, bcl-X, and bax in Malignant Mesothelioma Clin. Cancer Res., November 1, 1999; 5(11): 3508 - 3515. [Abstract] [Full Text] [PDF]

				M. A. Hotz, J. Bosq, P. Zbaeren, J. Reed, G. Schwab, S. Krajewski, P. Brousset, and M. M. Borner Spontaneous Apoptosis and the Expression of p53 and Bcl-2 Family Proteins in Locally Advanced Head and Neck Cancer Arch Otolaryngol Head Neck Surg, April 1, 1999; 125(4): 417 - 422. [Abstract] [Full Text] [PDF]

				M. P. Waalkes and B. A. Diwan Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: role of apoptosis Carcinogenesis, January 1, 1999; 20(1): 65 - 70. [Abstract] [Full Text] [PDF]

				Y. Soini, P. Paakko, and V-P. Lehto Histopathological Evaluation of Apoptosis in Cancer Am. J. Pathol., October 1, 1998; 153(4): 1041 - 1053. [Full Text] [PDF]